A recent study conducted by researchers from the University of Illinois Urbana-Champaign concluded that, when sampling powdered infant formula for Cronobacter contamination, sampling with stratification may be more powerful than random sampling, and that taking more samples, even if smaller, increases the ability to detect contamination.
The U.S. Food and Drug Administration (FDA) has announced that the National Academies of Sciences, Engineering, and Medicine (NASEM) will conduct an independent study on challenges in the U.S. infant formula supply, market competition, and regulation.
The full committee of the National Advisory Committee on Microbiological Criteria for Foods (NACMCF) will hold a hybrid in-person and virtual public meeting on May 16, 2023, to provide an update on the Cyclospora cayetanensis in produce and Cronobacter in powdered infant formula subcommittee work.
In this bonus episode of Food Safety Matters, we speak with two MilliporeSigma food safety experts about recent foodborne illness outbreaks and food safety incidents linked to infant formula, risk factors for formula contamination, and how producers can ensure formula safety and regulatory compliance.
The U.S. Food and Drug Administration (FDA) will host two webinars to provide stakeholders with information on regulatory requirements and considerations for infant formula ingredients and packaging in May and June, respectively.
The Canadian Food Inspection Agency (CFIA) has revised a guidance document regarding Safe Food for Canadians licensing requirements for manufacturers and importers of infant formula and human milk fortifier.
The U.S. Food and Drug Administration (FDA) has revised the guidance, titled, Labeling of Certain Beers Subject to the Labeling Jurisdiction of FDA, as well as two other guidances, to add “sesame” to the list of major food allergens for labeling purposes.
On March 8, 2023, the U.S. Food and Drug Administration (FDA) released an Immediate National Strategy to Increase the Resiliency of the U.S. Infant Formula Market. On the same day, the agency’s response to the recent infant formula safety and supply crisis was called into question during a hearing with the U.S. House of Representatives Subcommittee on Health Care and Financial Services Hearing.
